Med Life SA · BVB:M

Med Life SA — 9M 2019 Earnings Presentation

13 slides from Med Life SA's earnings presentation, Nov 14, 2019

  1. Slide 1: MedLife Group 9m 2019 Financial Results

    MedLife Group 9m 2019 Financial Results November 14, 2019

  2. Slide 2: Legal Disclaimer

    Legal Disclaimer This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of Med Life SA’s securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy Med Life SA’s securities. Neither this presentat

  3. Slide 3: Agenda

    Agenda Page I. MAIN EVENTS Q3/19 AND SUBSEQUENT EVENTS 4 II. KEY MESSAGES 9m 2019 5 III. 9m 2019 FINANCIAL SNAPSHOT 7 - Consolidated Statement of Financial Position - Consolidated Statement of Profit and Loss - Consolidated Statement of Cash Flow - OPEX Evolution IV. OPERATIONAL KPIs FOR 9m 2019 11

  4. Slide 4: Main Events Q3/19 and Subsequent Events

    Main Events Q3/19 and Subsequent Events ACQUISITIONS • 75% of the shares in Onco Team Diagnostic, Bucharest (finalized in October 2019) - one laboratory; EUR 1.1m Turnover in 2018 • 100% of the shares in Lotus Hospital, Ploiesti (signed in October 2019) - outpatient unit, imaging center, laboratory

  5. Slide 5: Key messages 9m 2019

    Key messages 9m 2019 Sales increased by : + 20.1% Pro-forma 9m 2019 vs. IFRS 9m 2018 SALES + 22.7% IFRS 9m 2019 vs. IFRS 9m 2018 + 14.9% like2like Improved margin: 13.1% Pro-forma 9m 2019 vs. 12.1% IFRS 9m 2018 (fig_1) (before IFRS 16) 17.1% Pro-forma 9m 2019 vs. 12.1% IFRS 9m 2018 (fig_2) (after IF

  6. Slide 6: Key messages 9m 2019 (Cont.)

    Key messages 9m 2019 (Cont.) Split of Pro-forma EBITDA between Owners of the Group / NCI for 9m 2019: 9.3% 90.7% - 90.7% to Group Owners EBITDA - 9.3% to NCI Pro-forma EBITDA to Group Owners Pro-forma EBITDA to NCI Improved margin: 6.8% Pro-forma 9m 2019 vs. 4.8% IFRS 9m 2018 (before IFRS 16) 7.0% P

  7. Slide 7: Consolidated Statement of Financial Position

    9m 2019 Financial Snapshot Consolidated Statement of Financial Position Page 7

  8. Slide 8: Consolidated Statement of Profit and Loss

    9m 2019 Financial Snapshot Consolidated Statement of Profit and Loss Page 8

  9. Slide 9: Consolidated Statement of Cash Flow

    9m 2019 Financial Snapshot Consolidated Statement of Cash Flow Page 9

  10. Slide 10: OPEX Evolution

    9m 2019 Financial Snapshot OPEX Evolution Note: The Group recorded a 1.5 p.p. decrease of Operating Expenses as % of Sales in 9m 2019 as compared to 9m 2018: A. 4.6 p.p. decrease of “Rent” as % of Sales, generated by first time adoption of IFRS 16; B. 1.0 p.p. increase of “Third parties and salaries

  11. Slide 11: Operational KPIs for 9m 2019

    Operational KPIs for 9m 2019 Page 11

  12. Slide 12: IV. Q&A SESSION

    © Med Life IV. Q&A SESSION RHSNe Page 12

  13. Slide 13: THANK YOU!

    THANK YOU! © MedLife

MedLife Group — 9M 2019 Earnings Presentation on 6ix